CVS第四季度业绩超预期，维持展望

Group 1 - CVS Health reported a 2.6% increase in stock price following the announcement of fourth-quarter revenue and earnings per share that exceeded expectations [1] - The company reaffirmed its earnings per share guidance for 2026, projecting between $7.00 and $7.20 [1] - CVS maintained its revenue guidance of no less than $400 billion, attributed to improved profit margins at Aetna and benefits from new prescription initiatives at Caremark [1]